260 related articles for article (PubMed ID: 31554418)
21. Prevention of raised low-density lipoprotein cholesterol in a patient with familial hypercholesterolaemia and lipoprotein lipase deficiency.
Zambon A; Torres A; Bijvoet S; Gagne C; Moorjani S; Lupien PJ; Hayden MR; Brunzell JD
Lancet; 1993 May; 341(8853):1119-21. PubMed ID: 8097805
[TBL] [Abstract][Full Text] [Related]
22. Coronary computed tomographic angiography findings and their therapeutic implications in asymptomatic patients with familial hypercholesterolemia. Lessons from the SAFEHEART study.
Pérez de Isla L; Alonso R; Muñiz-Grijalvo O; Díaz-Díaz JL; Zambón D; Miramontes JP; Fuentes F; Gómez de Diego JJ; González-Estrada A; Mata N; Saltijeral A; Barreiro M; Tomás M; de Andrés R; Argüeso R; Serrano Gotarredona MP; Navarro Herrero S; Perea Palazón RJ; de Caralt TM; Suárez de Centi LA; Zhilina S; Espejo Pérez S; Padró T; Mata P;
J Clin Lipidol; 2018; 12(4):948-957. PubMed ID: 29753733
[TBL] [Abstract][Full Text] [Related]
23. Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations.
Torres AL; Moorjani S; Vohl MC; Gagné C; Lamarche B; Brun LD; Lupien PJ; Després JP
Atherosclerosis; 1996 Sep; 126(1):163-71. PubMed ID: 8879444
[TBL] [Abstract][Full Text] [Related]
24. An age-matched computed tomography angiographic study of coronary atherosclerotic plaques in patients with familial hypercholesterolaemia.
Pang J; Abraham A; Vargas-García C; Bates TR; Chan DC; Hooper AJ; Bell DA; Burnett JR; Schultz CJ; Watts GF
Atherosclerosis; 2020 Apr; 298():52-57. PubMed ID: 32171980
[TBL] [Abstract][Full Text] [Related]
25. Serum low density lipoprotein cholesterol level and cholesterol absorption efficiency are influenced by apolipoprotein B and E polymorphism and by the FH-Helsinki mutation of the low density lipoprotein receptor gene in familial hypercholesterolemia.
Gylling H; Aalto-Setälä K; Kontula K; Miettinen TA
Arterioscler Thromb; 1991; 11(5):1368-75. PubMed ID: 1911722
[TBL] [Abstract][Full Text] [Related]
26. Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.
Mattina A; Rosenbaum D; Bittar R; Bonnefont-Rousselot D; Noto D; Averna M; Bruckert E; Giral P
Nutr Metab Cardiovasc Dis; 2018 May; 28(5):517-523. PubMed ID: 29525223
[TBL] [Abstract][Full Text] [Related]
27. Angiographic progression of coronary atherosclerosis in patients with familial hypercholesterolaemia treated with non-statin therapy: Impact of a fat-modified diet and a resin.
Watts GF; Pang J; Chan DC; Brunt JNH; Lewis B
Atherosclerosis; 2016 Sep; 252():82-87. PubMed ID: 27508319
[TBL] [Abstract][Full Text] [Related]
28. Achilles tendon xanthomas are associated with the presence and burden of subclinical coronary atherosclerosis in heterozygous familial hypercholesterolemia: A pilot study.
Mangili LC; Miname MH; Silva PRS; Bittencourt MS; Rocha VZ; Mangili OC; Salgado Filho W; Chacra AP; Jannes CE; Pereira AC; Santos RD
Atherosclerosis; 2017 Aug; 263():393-397. PubMed ID: 28499609
[TBL] [Abstract][Full Text] [Related]
29. Reducing cardiovascular risk in patients with familial hypercholesterolemia: Risk prediction and lipid management.
Miname MH; Santos RD
Prog Cardiovasc Dis; 2019; 62(5):414-422. PubMed ID: 31669498
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular risk factor profiles in familial hypercholesterolemia patients with and without genetic mutation compared to a nationally representative sample of adults in a high-risk European country.
Chlebus K; Zdrojewski T; Gruchała M; Gałąska R; Pajkowski M; Kocejko MR; Chmara M; Pencina MJ
Am Heart J; 2019 Dec; 218():32-45. PubMed ID: 31706143
[TBL] [Abstract][Full Text] [Related]
31. Effect of simvastatin in familial hypercholesterolemia on the affinity of electronegative low-density lipoprotein subfractions to the low-density lipoprotein receptor.
Benítez S; Ordóñez-Llanos J; Franco M; Marín C; Paz E; López-Miranda J; Otal C; Pérez-Jiménez F; Sánchez-Quesada JL
Am J Cardiol; 2004 Feb; 93(4):414-20. PubMed ID: 14969613
[TBL] [Abstract][Full Text] [Related]
32. The effect of an apolipoprotein A-I-containing high-density lipoprotein-mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia: The Modifying Orphan Disease Evaluation (MODE) study.
Hovingh GK; Smits LP; Stefanutti C; Soran H; Kwok S; de Graaf J; Gaudet D; Keyserling CH; Klepp H; Frick J; Paolini JF; Dasseux JL; Kastelein JJ; Stroes ES
Am Heart J; 2015 May; 169(5):736-742.e1. PubMed ID: 25965722
[TBL] [Abstract][Full Text] [Related]
33. Systematic analysis of variants related to familial hypercholesterolemia in families with premature myocardial infarction.
Brænne I; Kleinecke M; Reiz B; Graf E; Strom T; Wieland T; Fischer M; Kessler T; Hengstenberg C; Meitinger T; Erdmann J; Schunkert H
Eur J Hum Genet; 2016 Feb; 24(2):191-7. PubMed ID: 26036859
[TBL] [Abstract][Full Text] [Related]
34. Risk factors of atherosclerotic tissue types in single-vessel and intermediate coronary lesions: a cross-sectional study.
Wang X; Chen Q; Xu Y; Wang Y; Yang Y; Gu M; Xu H; Zhao Y
Lipids Health Dis; 2017 Mar; 16(1):63. PubMed ID: 28335787
[TBL] [Abstract][Full Text] [Related]
35. In pediatric familial hypercholesterolemia, lipoprotein(a) is more predictive than LDL-C for early onset of cardiovascular disease in family members.
Zawacki AW; Dodge A; Woo KM; Ralphe JC; Peterson AL
J Clin Lipidol; 2018; 12(6):1445-1451. PubMed ID: 30150142
[TBL] [Abstract][Full Text] [Related]
36. Circulating miR-6821-5p levels and coronary calcification in asymptomatic familial hypercholesterolemia patients.
Escate R; Padró T; Pérez de Isla L; Fuentes F; Alonso R; Mata P; Badimon L
Atherosclerosis; 2024 May; 392():117502. PubMed ID: 38513437
[TBL] [Abstract][Full Text] [Related]
37. Relationship of Familial Hypercholesterolemia and High Low-Density Lipoprotein Cholesterol to Ischemic Stroke: Copenhagen General Population Study.
Beheshti S; Madsen CM; Varbo A; Benn M; Nordestgaard BG
Circulation; 2018 Aug; 138(6):578-589. PubMed ID: 29593013
[TBL] [Abstract][Full Text] [Related]
38. Assessment of subclinical atherosclerosis and intraplaque neovascularization using quantitative contrast-enhanced ultrasound in patients with familial hypercholesterolemia.
van den Oord SC; Akkus Z; Roeters van Lennep JE; Bosch JG; van der Steen AF; Sijbrands EJ; Schinkel AF
Atherosclerosis; 2013 Nov; 231(1):107-13. PubMed ID: 24125419
[TBL] [Abstract][Full Text] [Related]
39. Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants in Patient Lymphocytes to Assess the Effect of Evinacumab in Homozygous Familial Hypercholesterolemia Patients With a Spectrum of LDLR Activity.
Banerjee P; Chan KC; Tarabocchia M; Benito-Vicente A; Alves AC; Uribe KB; Bourbon M; Skiba PJ; Pordy R; Gipe DA; Gaudet D; Martin C
Arterioscler Thromb Vasc Biol; 2019 Nov; 39(11):2248-2260. PubMed ID: 31578082
[TBL] [Abstract][Full Text] [Related]
40. Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature review.
Narverud I; Retterstøl K; Iversen PO; Halvorsen B; Ueland T; Ulven SM; Ose L; Aukrust P; Veierød MB; Holven KB
Atherosclerosis; 2014 Aug; 235(2):299-309. PubMed ID: 24908240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
